17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts



Status:Completed
Conditions:Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:12 - 75
Updated:4/2/2016
Start Date:November 2011
End Date:March 2014
Contact:Michael Grossman, DPM
Email:michaelrgrossman@hotmail.com
Phone:610-645-6314

Use our guide to learn which trials are right for you!

New Formulation of Salicylate to Improve Treatment of Common Skin Warts

Plantar warts on the sole of the foot are among the most common warts seen in podiatry
clinics. Some patients are readily cured by simple standard of care treatments that include
wart debridement (trimming or excision) and application of 17% salicylate (commercially
known as Compound W)or by other treatments that may be painful and affect mobility. No
treatment is consistently effective and most patients fail treatment multiple times.

Ethyl pyruvate (EP)is a common food additive noted to be 'generally regarded as safe' that
may improve the activity of salicylate in wart treatment by improving the ability to
penetrate and/or persist in the skin. The use of 17% salicylate with the addition of EP may
improve cures of common foot plantar warts in subjects who also be receiving other
standard-of-care treatment.


Inclusion Criteria:

- evidence of skin plantar wart(s)

Exclusion Criteria:

- iodine allergy
We found this trial at
1
site
Ardmore, Pennsylvania 19003
?
mi
from
Ardmore, PA
Click here to add this to my saved trials